.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
In India, high out-of-pocket medical expenditure remains a persistent challenge for millions of families. Consequently, structured healthcare financing has emerged as an essential lifeline to bridge the accessibility gap. CarePal Money, an integrated lending marketplace, recently crossed a major milestone by exceeding an annualized disbursement run rate of ₹150 crore. This achievement represents a significant 50% increase from its ₹100 crore milestone reached just a few months prior. Ultimately, as healthcare costs continue to climb, such financial models are transforming patient care delivery across the country.
Presently, Indian households bear a disproportionate share of medical costs because health insurance coverage remains low. Indeed, recent data indicates that Indian patients pay over 40% of healthcare expenses directly out of pocket. Accordingly, platforms like CarePal Money provide flexible, zero-percent interest lending options. Therefore, patients can receive timely clinical interventions without delayed decisions. Additionally, hospitals can minimize revenue leakage and improve patient retention rates.
Traditional non-banking financial companies (NBFCs) often overlook complex, high-cost therapies. However, specialized fintech platforms are filling this gap by financing expensive procedures, such as oncology care and advanced surgeries. For instance, partnerships with pharmaceutical companies facilitate structured loans for cutting-edge treatments like CAR T-cell therapy. As a result, underserved patient segments gain immediate access to life-saving clinical solutions. Furthermore, larger average ticket sizes allow families to manage comprehensive medical emergencies comfortably.
Medical inflation in India is rising at an estimated rate of 14% annually, significantly outpacing general economic inflation. Consequently, even middle-class households struggle to afford critical and elective secondary or tertiary care. To illustrate this, many families still rely on distress financing, such as selling assets or taking high-interest personal loans. Platforms offering structured healthcare financing mitigate these severe financial risks. Thus, they protect vulnerable populations from falling into deep medical debt traps.
Q1: What is the main driver behind the growth of CarePal Money?
The primary growth drivers are rising demands for structured financing and an expanding footprint across various Indian hospitals.
Q2: Why is structured healthcare financing crucial in India?
Structured financing is essential because Indian families pay over 40% of healthcare costs out of pocket. Consequently, under rising medical inflation, these flexible lending options prevent patients from delaying essential treatments.
Q3: How do zero-percent interest EMI models benefit hospitals?
Ultimately, these models help hospitals improve patient retention, reduce the frequency of patients leaving mid-treatment, and minimize overall revenue leakage.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
As out-of-pocket medical costs push millions of Indian families into financial distress, fintech players like CarePal Money are stepping in. By crossing an annualized disbursement run rate of ₹150 crore, the platform demonstrates a rising demand for zero-percent interest patient-focused lending solutions.
last month
A parliamentary panel has urged the FSSAI to finalise front-of-pack nutrition labelling regulations without further delay. The committee stressed that simple, color-coded indicators for sugar and clear warning labels are vital to combat dietary non-communicable diseases and guide informed consumer choices.
3 days back
A comprehensive analysis of the NFHS-5 data regarding postpartum anemia in India, exploring the prevalence, severity, and the socioeconomic and regional factors contributing to this public health challenge for clinicians seeking to improve maternal health outcomes.
Last week
A study in Greece reveals that 46-80% of heatwave deaths are linked to climate change. This analysis explores the implications for public health and clinical practice, particularly for elderly and vulnerable populations facing rising global temperatures in regions like India.
2 weeks back
Nearly 80% of Indians suffer from inadequate Vitamin D, causing silent bone weakening and sudden fractures. This expert guide reviews why mega-dose therapy is critical for high-risk patients, the key factors driving widespread deficiency, and the mandatory medical evaluations needed to protect skeletal health.
last month
A parliamentary standing committee has directed FSSAI to expedite front-of-pack nutrition labelling regulations. The panel highlighted that over two years of delay since the 2022 draft notification leaves consumers relying on complex numerical labels, urging simple color-coded sugar indicators and warnings.
3 days back
